药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Lumiracoxib
Entrectinib
The metabolism of Entrectinib can be increased when combined with Vemurafenib.
Lumiracoxib
Alpelisib
The serum concentration of Alpelisib can be increased when it is combined with Vemurafenib.
Lumiracoxib
Metildigoxin
Vemurafenib may decrease the excretion rate of Metildigoxin which could result in a higher serum level.
Lumiracoxib
Erdafitinib
The serum concentration of Vemurafenib can be increased when it is combined with Erdafitinib.
Lumiracoxib
Thyrotropin
The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Benzylthiouracil
The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Elcatonin
The therapeutic efficacy of Elcatonin can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Methylthiouracil
The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Vemurafenib.
Lumiracoxib
3,5-diiodothyropropionic acid
The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Protirelin
The therapeutic efficacy of Protirelin can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Potassium perchlorate
The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Thyroid, porcine
The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Dibromotyrosine
The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Potassium Iodide
The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Teriparatide
The therapeutic efficacy of Teriparatide can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Parathyroid hormone
The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Abaloparatide
The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Tiratricol
The therapeutic efficacy of Tiratricol can be decreased when used in combination with Vemurafenib.
Lumiracoxib
3,5-Diiodotyrosine
The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Vemurafenib.
Lumiracoxib
Cholestyramine
Cholestyramine can cause a decrease in the absorption of Vemurafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.